Kaj Metsärinne
- Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trialRenal vascular resistance is increased in patients with kidney transplant (2019)
- European Heart JournalBMC Nephrology
- Exome sequencing of Finnish isolates enhances rare-variant association power (2019)
- NatureJournal of the American College of Cardiology
- Genetic architecture of human plasma lipidome and its link to cardiovascular disease (2019)
- Nature CommunicationsCirculation Journal
- Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus AspirinSafety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin (2019)
- Journal of the American College of CardiologyGastroenterology
- Munuaispotilaan sydän- ja verisuonitautien riskit (2019)
- Lääkärilehti
- Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled TrialStroke outcomes in the COMPASS Trial (2019)
- GastroenterologyCirculation Journal
- (2019)
- Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction From the COMPASS Trial (2019)
- Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease (2019)
- (2019)
- Soluble receptor for AGE in diabetic nephropathy and its progression in Finnish individuals with type 1 diabetes (2019)
- Diabetologia
- (2019)
- (2019)
- BMC Cardiovascular Disorders
- Association between depressive symptoms and dietary intake in patients with type 1 diabetesAssociation between adherence to dietary recommendations and high-sensitivity C-reactive protein level in type 1 diabetes (2018)
- Diabetes Research and Clinical PracticeDiabetes Research and Clinical Practice
- Kohonneen verenpaineen hoito tehostuu (2018)
- BestPractice Diabetes ja sydänsairaudet
- Lääkkeiden aiheuttama munuaisvaurio - optimaalinen lääkitys huomioi riskit ja hyödyt (2018)
- Sic! : lääketietoa Fimeasta
- Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial (2018)
- Lancet
- The renal blood flow reserve in healthy humans and patients with atherosclerotic renovascular disease measured by positron emission tomography using [O-15]H2O (2018)
- EJNMMI Research
- Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes (2017)
- Kidney International
- (2017)



